Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals

American Journal of Pathology

Volumn 156, Issue 1, 2000, Pages 151-158

  Sauer, H ^a   Gunther, J ^a   Hescheler, J ^a   Wartenberg, M ^a  

^a Department of Neurophysiology ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYL RADICAL; REACTIVE OXYGEN METABOLITE; THALIDOMIDE;

ANGIOGENESIS; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; EMBRYO; EMBRYO DEVELOPMENT; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL;

EID: 0033876198     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64714-1     Document Type: Article

References (24)

1. Thalidomide and congenital abnormalities
2. Thalidomide and congential abnormalities Lancet
3. Angiogenesis: The unifying concept in cancer?
4. Proposed mechanisms of action in thalidomide embryopathy
5. Thalidomide is an inhibitor of angiogenesis
6. Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization
7. Oxidative damage in chemical teratogenesis
8. Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity
9. The embryoid body as a novel in vitro assay system for antiangiogenic agents
10. Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps
11. Vasculogenesis and angiogenesis in embryonic stem-cell-derived embryoid bodies
12. Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector
13. Doxorubicin distribution in multicellular prostate cancer spheroids evaluated by confocal laser scanning microscopy and the 'optical probe technique'
14. Quantitative recording of vitality patterns in living multicellular spheroids by confocal microscopy
15. Hydrogen peroxide formation by cells treated with a tumor promoter
16. Evidence for accelerated generation of hydroxyl radicals in experimental obstructive jaundice of rats
17. Conversion of nitroxide radicals by phenolic and thiol antioxidants
18. Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent
19. Effects of maternal thalidomide treatment on pregnancy, fetal development, and mortality of the offspring in random-bred mice
20. Non-confirmation of thalidomide induced teratogenesis in rats and mice
21. Mechanisms of endothelial cell injury in acute inflammation
22. Evidence for embryonic prostagiandin H synthase-catalyzed bioactivation and reactive oxygen species-mediated oxidation of cellular macromolecules in phenytoin and benzo[a]pyrene teratogenesis
23. Histopathological and hemodynamic studies supporting hypoxia and vascular disruption as explanation to phenytoin teratogenicity
24. Phenytoin causes phalangeal hypoplasia in the rabbit fetus at clinically relevant free plasma concentrations